|
| Status |
Public on Sep 30, 2020 |
| Title |
GRB10 sustains AR activity by interacting with PP2A in prostate cancer cells |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by array
|
| Summary |
Prostate cancer (PCa) progression is driven by androgen receptor (AR) signaling. Unfortunately, androgen-deprivation therapy and the use of even more potent AR pathway inhibitors (ARPI) cannot bring about a cure. ARPI resistance (i.e. castration-resistant PCa, CRPC) will inevitably develop. Previously, we demonstrated that GRB10 is an AR transcriptionally-repressed gene that functionally contributes to CRPC development and ARPI resistance. GRB10 expression is elevated prior to CRPC development in our patient-derived xenograft models and is significantly upregulated in clinical CRPC samples. Here, we analyzed transcriptomic data from GRB10 knockdown in PCa cells and found that AR signaling is downregulated. While the mRNA expression of AR target genes decreased upon GRB10 knockdown, AR expression was not affected at the mRNA or protein level. We further found that phosphorylation of AR serine 81 (S81), which is critical for AR transcriptional activity, is decreased by GRB10 knockdown and increased by its overexpression. Luciferase assay using GRB10-knockdown cells also indicated reduced AR activity. Immunoprecipitation coupled with mass spectrometry revealed an interaction between GRB10 and the PP2A complex, which is a known phosphatase of AR. Further validations and analyses showed that GRB10 directly binds to the PP2Ac catalytic subunit with its PH domain. Mechanistically, GRB10 knockdown increased PP2Ac protein stability, which in turn decreased AR S81 phosphorylation and reduced AR activity. Our findings indicate a reciprocal feedback between GRB10 and AR signaling, implying the importance of GRB10 in PCa progression.
|
| |
|
| Overall design |
LNCaP cell was transduced with lentiviral particles delivering control or GRB10 shRNA. Total RNA was extracted from stable cell lines, and applied for gene expression profiling analysis using Agilent SurePrint G3 Human Gene Expression v3 8x60K array.
|
| |
|
| Contributor(s) |
Hao J, Haegert AM, Lin D, Wang Y |
| Citation(s) |
33038264 |
| Submission date |
Apr 20, 2020 |
| Last update date |
Dec 30, 2020 |
| Contact name |
Yuzhuo Wang |
| Organization name |
University of British Columbia
|
| Department |
Vancouver Prostate Centre
|
| Lab |
The Living Tumor Laboratory
|
| Street address |
2660 Oak Street
|
| City |
Vancouver |
| State/province |
BC |
| ZIP/Postal code |
V6H 3Z6 |
| Country |
Canada |
| |
|
| Platforms (1) |
| GPL21185 |
Agilent-072363 SurePrint G3 Human GE v3 8x60K Microarray 039494 [Probe Name Version] |
|
| Samples (4)
|
|
| Relations |
| BioProject |
PRJNA626663 |
Less...
More...